142 related articles for article (PubMed ID: 34474246)
1. Kinesin 12 (KIF15) contributes to the development and tumorigenicity of prostate cancer.
Qureshi Z; Ahmad M; Yang WX; Tan FQ
Biochem Biophys Res Commun; 2021 Oct; 576():7-14. PubMed ID: 34474246
[TBL] [Abstract][Full Text] [Related]
2. KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway.
Wang J; Guo X; Xie C; Jiang J
Br J Cancer; 2017 Jul; 117(2):245-255. PubMed ID: 28595260
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of KIF15 inhibits the tumorigenesis of non-small-cell lung cancer via inactivating Raf/MEK/ERK signaling.
Luo Y; Zhang B; Xu L; Li M; Wu J; Zhou Y; Li Y
Histol Histopathol; 2022 Mar; 37(3):269-285. PubMed ID: 34908156
[TBL] [Abstract][Full Text] [Related]
4. KIF15 plays a role in promoting the tumorigenicity of melanoma.
Yu X; He X; Heindl LM; Song X; Fan J; Jia R
Exp Eye Res; 2019 Aug; 185():107598. PubMed ID: 30797758
[TBL] [Abstract][Full Text] [Related]
5. KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer.
Gao L; Zhang W; Zhang J; Liu J; Sun F; Liu H; Hu J; Wang X; Wang X; Su P; Chen S; Qu S; Shi B; Xiong X; Chen W; Dong X; Han B
Cancer Res; 2021 Feb; 81(4):1026-1039. PubMed ID: 33277366
[TBL] [Abstract][Full Text] [Related]
6. Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer.
Zhang Z; Chai C; Shen T; Li X; Ji J; Li C; Shang Z; Niu Y
Dis Markers; 2019; 2019():4782730. PubMed ID: 31565099
[TBL] [Abstract][Full Text] [Related]
7. PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer.
Zhang H; Li C; Liao S; Tu Y; Sun S; Yao F; Li Z; Wang Z
Cancer Biol Ther; 2022 Dec; 23(1):1-11. PubMed ID: 36137220
[TBL] [Abstract][Full Text] [Related]
8. KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species-mediated apoptosis.
Tao J; Sun G; Li Q; Zhi X; Li Z; He Z; Chen H; Zhou A; Ye J; Xu G; Guan W; Zhang W
J Cell Physiol; 2020 Dec; 235(12):9388-9398. PubMed ID: 32342525
[TBL] [Abstract][Full Text] [Related]
9. Kinesin family member 15 can promote the proliferation of glioblastoma.
Wang L; Zhang X; Liu J; Liu Q
Math Biosci Eng; 2022 Jun; 19(8):8259-8272. PubMed ID: 35801464
[TBL] [Abstract][Full Text] [Related]
10. KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma.
Sun YF; Wu HL; Shi RF; Chen L; Meng C
Anal Cell Pathol (Amst); 2020; 2020():6403012. PubMed ID: 32318326
[TBL] [Abstract][Full Text] [Related]
11. Identification of KIF15 as a potential therapeutic target and prognostic factor for glioma.
Wang Q; Han B; Huang W; Qi C; Liu F
Oncol Rep; 2020 Apr; 43(4):1035-1044. PubMed ID: 32323839
[TBL] [Abstract][Full Text] [Related]
12. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
[TBL] [Abstract][Full Text] [Related]
13. VIRMA Facilitates Triple-Negative Breast Cancer Progression via Increasing m6A-Dependent KIF15 Expression.
Chen C; Wang Y; Li Y; Zhang C
Discov Med; 2023 Oct; 35(178):787-795. PubMed ID: 37811616
[TBL] [Abstract][Full Text] [Related]
14. High KIFC1 expression is associated with poor prognosis in prostate cancer.
Kostecka LG; Olseen A; Kang K; Torga G; Pienta KJ; Amend SR
Med Oncol; 2021 Mar; 38(5):47. PubMed ID: 33760984
[TBL] [Abstract][Full Text] [Related]
15. Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.
Qiao Y; Chen J; Ma C; Liu Y; Li P; Wang Y; Hou L; Liu Z
Cell Physiol Biochem; 2018; 51(1):1-10. PubMed ID: 30439711
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.
Chen C; Cai Z; Zhuo Y; Xi M; Lin Z; Jiang F; Liu Z; Wan Y; Zheng Y; Li J; Zhou X; Zhu J; Zhong W
BMC Cancer; 2020 Apr; 20(1):289. PubMed ID: 32252682
[TBL] [Abstract][Full Text] [Related]
17. KIF15 contributes to cell proliferation and migration in breast cancer.
Gao X; Zhu L; Lu X; Wang Y; Li R; Jiang G
Hum Cell; 2020 Oct; 33(4):1218-1228. PubMed ID: 32578050
[TBL] [Abstract][Full Text] [Related]
18. KIF15 knockdown suppresses gallbladder cancer development.
Wang J; Wang D; Fei Z; Feng D; Zhang B; Gao P; Hu G; Li W; Huang X; Chen D; Ding X; Wu W
Eur J Cell Biol; 2021; 100(7-8):151182. PubMed ID: 34781077
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Rab23 in Prostate Cancer Inhibits Tumor Growth In Vitro and In Vivo.
Chang J; Xu W; Liu G; Du X; Li X
Oncol Res; 2017 Jan; 25(2):241-248. PubMed ID: 28277196
[TBL] [Abstract][Full Text] [Related]
20. Kinesin superfamily member 15 knockdown inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma.
Cai Y; Lai Q; Zhang X; Zhang Y; Zhang M; Gu S; Qin Y; Hou J; Zhao L
Korean J Physiol Pharmacol; 2023 Sep; 27(5):457-470. PubMed ID: 37641808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]